Genentech’s TECENTRIQ in Combination With Pemetrexed and Platinum-Based Chemotherapy Reduced the Risk of Disease Worsening or Death Pharmaceutical Investing
Applied DNA Subsidiary, LineaRx Signs Joint Development Agreement with Takis and Evvivax Genetics Investing
Molecular Templates Announces Agreement with Takeda for the Joint Development of a Protein-Based Oncology Therapy Genetics Investing
ChromaDex Announces Strategic Partnership for Aging Research with Jiangxi Government in China Longevity Investing
Fluidigm Partners with GenomOncology to Provide a Comprehensive Immuno-Oncology Gene Expression Solution on Biomark HD Biotech Investing
ProQR Announces Positive Interim Results from Phase 1/2 Clinical Trial of QR-110 in LCA10 Patients, and Plans to Start a Phase 2/3 Pivotal Trial Genetics Investing